# Bristol-Myers Squibb Company (BMY) — Q2-2013 Earnings Results

**Report date:** 2013-07-25 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BMY/earnings/Q2-2013

## Post-Earnings Brief

### Headline

Bristol Myers Squibb Beats on EPS, Stock Down 1.48%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.44 | N/A | +1.15% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Management conveyed a cautious optimism about future growth despite current market challenges. They emphasized their focus on innovation and product development.

**Key quotes:**

> Management highlighted ongoing commitment to innovation.

> They acknowledged challenges in the market but expressed confidence in pipeline products.

### Guidance Changes

No guidance updates were provided during the earnings call.

### What It Means

Bristol Myers Squibb's earnings report shows a slight beat on EPS, which indicates some positive momentum. However, the stock fell by 1.48%, likely due to the lack of revenue details and no updated guidance. Investors may be concerned about the company's future performance without clearer financial expectations.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BMY/earnings/Q2-2013_